Wen Zhao

1.7k total citations
35 papers, 1.2k citations indexed

About

Wen Zhao is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Wen Zhao has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Genetics. Recurrent topics in Wen Zhao's work include Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Wen Zhao is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Wen Zhao collaborates with scholars based in China, United States and New Zealand. Wen Zhao's co-authors include Hong‐Min Liu, Yi‐Chao Zheng, Evangelia G. Kranias, Jinlian Ma, Jinfeng Li, Wenjuan Zhou, Junwei Wang, Guo‐Chang Fan, Xiaojing Shi and Zhi-Ru Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation Research and Bioresource Technology.

In The Last Decade

Wen Zhao

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Zhao China 18 814 182 154 100 97 35 1.2k
Haloom Rafehi Australia 15 585 0.7× 69 0.4× 126 0.8× 110 1.1× 78 0.8× 32 1.0k
Lipeng Xu China 22 503 0.6× 102 0.6× 69 0.4× 69 0.7× 81 0.8× 57 1.3k
Nir Qvit United States 17 1.4k 1.7× 154 0.8× 107 0.7× 88 0.9× 51 0.5× 45 1.8k
Huifang Li China 19 552 0.7× 80 0.4× 57 0.4× 122 1.2× 176 1.8× 77 1.3k
Seung Hun Jeong South Korea 17 546 0.7× 75 0.4× 56 0.4× 178 1.8× 50 0.5× 33 854
Hirofumi Nishikawa Japan 24 450 0.6× 174 1.0× 39 0.3× 69 0.7× 50 0.5× 78 1.4k
Hong‐Ye Zhao China 21 878 1.1× 112 0.6× 77 0.5× 280 2.8× 202 2.1× 82 1.5k
Carina L. Bos Netherlands 14 473 0.6× 105 0.6× 49 0.3× 141 1.4× 113 1.2× 17 1.4k
Xiang Liu China 21 508 0.6× 48 0.3× 48 0.3× 106 1.1× 94 1.0× 85 1.2k

Countries citing papers authored by Wen Zhao

Since Specialization
Citations

This map shows the geographic impact of Wen Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Zhao more than expected).

Fields of papers citing papers by Wen Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Zhao. The network helps show where Wen Zhao may publish in the future.

Co-authorship network of co-authors of Wen Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Zhao. A scholar is included among the top collaborators of Wen Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Zhao. Wen Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xinbin, et al.. (2024). HAX-1 interferes in assembly of NLRP3-ASC to block microglial pyroptosis in cerebral I/R injury. Cell Death Discovery. 10(1). 264–264. 5 indexed citations
3.
Zhao, Wen, Shasha Shen, Jie Jiang, et al.. (2023). Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma. European Radiology. 34(1). 16–25. 11 indexed citations
4.
Pan, Hao, et al.. (2022). Inhibition of lysine-specific demethylase 1 enhances the sensitivity of the chemotherapeutic drug doxorubicin in gastric cancer cell. Molecular Biology Reports. 50(1). 507–516. 4 indexed citations
5.
Yang, Xiaohang, Binbin Zhu, Wen Zhao, et al.. (2020). Aggravated endothelial endocrine dysfunction and intimal thickening of renal artery in high-fat diet-induced obese pigs following renal denervation. BMC Cardiovascular Disorders. 20(1). 176–176. 5 indexed citations
6.
Zhou, Wenjuan, Liying Ma, Jing Yang, et al.. (2019). Potent and specific MTH1 inhibitors targeting gastric cancer. Cell Death and Disease. 10(6). 434–434. 28 indexed citations
7.
Li, Jing, Deliang Shen, Junnan Tang, et al.. (2019). IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement. European Journal of Pharmacology. 854. 307–319. 19 indexed citations
8.
Lu, Zhaoming, Yandan Ren, Mengying Zhang, et al.. (2018). FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells. Biomedicine & Pharmacotherapy. 107. 1370–1376. 23 indexed citations
9.
Deng, Xin, Laijun Song, Wen Zhao, Ying Wei, & Xinbin Guo. (2017). HAX-1 Protects Glioblastoma Cells from Apoptosis through the Akt1 Pathway. Frontiers in Cellular Neuroscience. 11. 420–420. 17 indexed citations
10.
Bidwell, Philip A., Narayani Nagarajan, Chi Keung Lam, et al.. (2017). HAX-1 regulates SERCA2a oxidation and degradation. Journal of Molecular and Cellular Cardiology. 114. 220–233. 20 indexed citations
11.
Shi, Xiaojing, Lina Ding, Wenjuan Zhou, et al.. (2016). Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I. Antioxidants and Redox Signaling. 27(2). 73–92. 26 indexed citations
12.
Yu, Bin, et al.. (2016). Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment. Current Topics in Medicinal Chemistry. 16(19). 2179–2188. 77 indexed citations
13.
Cai, Wenfeng, Guan‐Sheng Liu, Chi Keung Lam, et al.. (2015). Up-Regulation of Micro-RNA765 in Human Failing Hearts is Associated with Post-Transcriptional Regulation of Protein Phosphatase Inhibitor-1 and Depressed Contractility. European Journal of Heart Failure. 17(8). 782–793. 19 indexed citations
14.
Zheng, Yi‐Chao, Jinlian Ma, Zhiru Wang, et al.. (2015). A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors. Medicinal Research Reviews. 35(5). 1032–1071. 146 indexed citations
15.
Zhao, Wen, Guo‐Chang Fan, Zhiguo Zhang, et al.. (2008). Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis. Basic Research in Cardiology. 104(4). 377–389. 53 indexed citations
16.
Li, Zhi, Wen Zhao, Ruixue Li, et al.. (2008). Combustion characteristics and NO formation for biomass blends in a 35-ton-per-hour travelling grate utility boiler. Bioresource Technology. 100(7). 2278–2283. 34 indexed citations
17.
Song, Ge, Martina Hennessy, Yusheng Zhao, et al.. (2006). Adrenoceptor blockade alters plasma gelatinase activity in patients with heart failure and MMP-9 promoter activity in a human cell line (ECV304). Pharmacological Research. 54(1). 57–64. 12 indexed citations
18.
Liu, Weiping, Wen Zhao, & G A Chase. (2004). Genome scan meta-analysis for hypertension. American Journal of Hypertension. 17(12). 1100–1106. 30 indexed citations
19.
Fan, Guo‐Chang, Kimberly N. Gregory, Wen Zhao, Woo Jin Park, & Evangelia G. Kranias. (2004). Regulation of myocardial function by histidine-rich, calcium-binding protein. American Journal of Physiology-Heart and Circulatory Physiology. 287(4). H1705–H1711. 58 indexed citations
20.
Frank, Konrad, Guoxiang Chu, Karen Young, et al.. (2001). Structure and expression of the mouse cardiac calsequestrin gene. Basic Research in Cardiology. 96(6). 636–644. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026